TET2 and acquired polycythemia vera: The acquisition of JAK2V617F first, followed by TET2 mutation, was more likely to result in a PV phenotype, typically in younger patients, but if JAK2V617F was acquired on a TET2-mutated background (“TET2-first”), an ET phenotype was more frequent.